Key Findings — G13
- Pure or near-pure indica with Afghani genetic roots — precise parentage unverified; the most credible sourcing credits Neville Schoenmakers (The Seed Bank, 1980s), not a US government facility
- THC range of 18-24% places G13 firmly in the high-potency bracket — not suitable for beginners or daytime use
- Myrcene-dominant terpene profile (with Caryophyllene and Linalool) drives the deeply sedating, body-focused effect that defines the G13 experience
- Effects: powerful body sedation, euphoric head high, classic indica stone — pronounced couch-lock, long duration (2-4 hours), heavy munchies
- Medical primary applications: severe insomnia, chronic pain, anxiety, muscle spasms — the high Myrcene + Linalool combination provides notable sedative and anxiolytic activity
- G13 has contributed to a significant number of derivative crosses, most notably G13 Haze (G13 × Haze, Mr. Nice Seeds) which became a Cannabis Cup winner
- Grows in 8-9 weeks, moderate difficulty — dense buds require low humidity and good airflow to avoid botrytis in late flower
The G13 Legend — Mythology vs. Credible History
No cannabis strain carries more mythology per gram than G13. The core legend holds that the US government — variously attributed to the FBI, CIA, USDA, or a secretive military research programme — developed an extraordinarily potent indica cultivar at a facility in Mississippi (or occasionally California or Nevada, depending on the telling). A single cutting was allegedly stolen by a technician and passed to underground breeder Neville Schoenmakers, from which all modern G13 genetics supposedly descend.
This story is almost certainly false in its government-origin elements. Here is what is verifiable versus what is not:
| Claim | Status | Evidence / Context |
|---|---|---|
| US government facility created G13 | No evidence | No documentation, no named facility, no corroborating witnesses. USDA/NIDA Mississippi cannabis programme did exist but grew low-potency research specimens — not high-resin indica. |
| A single cutting was stolen by an insider | Unverified | No named whistleblower has ever come forward. The story proliferates in cannabis culture but lacks primary sources. |
| Neville Schoenmakers held G13 genetics | Plausible / credible | Neville was the pre-eminent Afghani-genetics collector in the 1980s. His Seed Bank catalogue referenced “government genetics” — this may be marketing, or a legitimate but exaggerated sourcing claim. |
| G13 is an Afghani-dominant indica | Confirmed by phenotype | The morphology, terpene profile, flowering time, and effects are entirely consistent with Afghan landrace genetics or F1-F3 Afghani hybrids. No sativa influence evident in the plant or the experience. |
| G13 is uniquely potent / a “super strain” | Partially true | At 18-24% THC G13 is potent, but not uniquely so by current commercial standards. The legend vastly inflated its potency claims (some versions claim 28%+ THC) beyond what is analytically documented. |
The more prosaic but credible origin: Neville sourced outstanding Afghani specimens during the Dutch cannabis breeding explosion of the 1980s — an era when landrace genetics from Afghanistan, India, Colombia, and Mexico arrived in Amsterdam through seed traders and travellers. The “government experiment” framing is most likely a mythology that Neville himself either invented for marketing purposes or that grew organically in the cannabis underground. Regardless of its origin, the genetics behind G13 are exceptional — the myth attached itself to a genuinely superior indica cultivar.
Terpene and Cannabinoid Profile
| Compound | Type | Level | Aroma | Effect Contribution |
|---|---|---|---|---|
| Myrcene | Primary terpene | High | Earthy, musky, herbal | Sedation, muscle relaxation, potency amplification via CB1 |
| Caryophyllene | Secondary terpene | Moderate | Spicy, peppery, woody | CB2 agonist — anti-inflammatory, anxiolytic, pain modulation |
| Linalool | Tertiary terpene | Lower | Floral, lavender, sweet | GABAergic sedation, anxiolytic, antiseizure properties |
| THC (THCA) | Cannabinoid | 18-24% | — | CB1 agonism — primary psychoactive, deep euphoria and sedation |
| CBD | Cannabinoid | Up to 1% | — | Mild CBD contribution may reduce acute anxiety edge |
The Myrcene + Linalool combination in G13 is pharmacologically significant: Myrcene potentiates CB1 agonism (increasing perceived THC intensity), while Linalool — familiar from lavender aromatherapy research — exerts GABAergic activity that contributes directly to the characteristic deep physical relaxation. Caryophyllene’s CB2 activity adds an anti-inflammatory layer particularly relevant for its pain-relief applications. See our guide on Myrcene and Beta-Caryophyllene for detailed profiles.
Effects — A Classic Indica Stone
G13 is not a nuanced strain. It is a powerful, blunt-force indica built for sedation, euphoria, and extended relaxation. Experienced users describe the onset as a spreading warmth that begins in the head and moves progressively through the body, reaching full effect within 20-30 minutes of inhalation.
Warm euphoric head rush. Mood lifts sharply. Sensory perception softens and expands. Initial cerebral clarity before the indica weight sets in.
Deep body sedation dominates. Classic couch-lock. Hunger intensifies. Mental activity slows to a comfortable haze. Eyes heavy.
Gradual drift toward sleep. Profound muscle relaxation persists. Morning-after grogginess possible with higher doses.
Not for beginners or daytime use. G13’s 18-24% THC combined with a Myrcene-heavy terpene profile produces an experience that can overwhelm inexperienced users. Start with a single small inhalation and allow a full 30 minutes before assessing. Edible versions are particularly intense and not recommended unless tolerance is well established.
G13 Derivatives and Legacy Strains
Despite (or perhaps because of) its murky origins, G13 has contributed to a meaningful catalogue of derivative strains, most of which attempt to balance its intense indica sedation with sativa elements for daytime viability.
| Strain | Cross | Breeder | Character | Notable Award |
|---|---|---|---|---|
| G13 Haze | G13 × Haze | Mr. Nice Seeds (Howard Marks / Shantibaba) | Balanced euphoria + sativa energy; long-lasting | High Times Cannabis Cup winner |
| Killing Fields | G13 × (undisclosed) | Sensi Seeds | Dense heavy indica; extreme resin production | — |
| G13 x Hash Plant | G13 × Hash Plant | Various | Maximum hash yield; pure body stone | — |
| Cinderella 99 | Jack Herer (G13 lineage present) × Shiva Skunk | Mr. Soul (Bros Grimm) | G13 genetics several generations removed; fruity sativa | Cannabis Cup 1999 |
| Multiple “G13” branded crosses | Varies by breeder | Many post-2000 seed companies | Quality varies widely; true G13 lineage unverified | — |
Medical Applications
G13’s high potency and sedating terpene profile make it best suited to conditions requiring significant sedation, pain control, or end-of-day relief. It is rarely the first choice for daytime medical use.
| Condition | Relevant Mechanism | Dose Note | Use Timing |
|---|---|---|---|
| Severe Insomnia | Myrcene + Linalool GABAergic sedation, THC sleep onset acceleration | 5-15mg THC eq. 30-60 min before bed | Evening only |
| Chronic Pain | CB1 + CB2 dual modulation; Caryophyllene anti-inflammatory | 5-20mg THC eq.; titrate to effect | Evening/night |
| Anxiety (severe) | Linalool GABA-A modulation; Caryophyllene CB2 anxiety signalling | Low doses only (2.5-5mg); high doses may increase anxiety | Evening; not acute daytime anxiety |
| Muscle Spasms | Myrcene muscle relaxant, CB1 spasticity reduction | Inhaled onset fastest for acute spasm relief | As needed; evening preferred |
Growing G13
| Parameter | Indoor | Outdoor | Notes |
|---|---|---|---|
| Flowering Time | 8-9 weeks (12/12) | Late September | Afghani genetics = shorter flower typical of landrace indica |
| Yield | 400-500 g/m² | 350-500 g/plant | Dense, heavy colas — support stakes recommended |
| Plant Height | 60-100 cm | 80-130 cm | Compact indica structure; suitable for small tents |
| Climate | 20-26°C, RH <45% in flower | Warm, dry harvest window | Dense buds = high botrytis risk in humid climates |
| Difficulty | Moderate | Moderate | Humidity management is the key skill |
| Watch For | Bud rot in late flower, nutrient sensitivity in final 2 weeks | Harvest timing — mould risk if delayed past trichome amber | Flush 10-14 days before harvest for clean flavour |
For growing guidance relevant to G13’s compact indica structure, see our Indoor Growing Basics and When to Harvest Cannabis guides. The Afghani genetics make G13 relatively forgiving in terms of nutrient errors but demand strict humidity control — a common cause of crop loss in its dense bud formations.
Cannabis indica genetics, trichome biology, and Afghani landrace heritage
Jordan Price has spent over a decade studying cannabis genetics, terpene chemistry, and cultivation techniques. His work on indica landrace genetics and Afghani-descended strains draws on hands-on grow experience and primary-source cannabis history research.